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Objective: Although osteoarthritis (OA) is considered a non-inﬂammatory condition, it is widely accepted
that synovial inﬂammation is a feature of OA. However, the role of immune cells and their cytokines in
OA is largely unknown. This narrative systematic review summarizes the knowledge of inﬂammatory
properties, immune cells and their cytokines in synovial tissues (STs) of OA patients.
Design: Broad literature search in different databases was performed which resulted in 100 articles.
Results: Of 100 articles 33 solely investigated inﬂammation in OA ST with or without comparison with
normal samples; the remaining primarily focussed on rheumatoid arthritis (RA) ST. Studies investi-
gating different severity stages or cellular source of cytokines were sparse. OA ST displayed mild/
moderate grade inﬂammation when investigated by means of haematoxylin and eosin (H&E) staining.
Most frequently found cells types were macrophages, T cells and mast cells (MCs). Overall the number
of cells was lower than in RA, although the number of MCs was as high as or sometimes even higher
than in RA ST. Cytokines related to T cell or macrophage function were found in OA ST. Their expression
was overall higher than in normal ST, but lower than in RA ST. Their cellular source remains largely
unknown in OA ST.
Conclusion: Inﬂammation is common in OA ST and characterized by immune cell inﬁltration and cytokine
secretion. This inﬂammation seems quantitatively and qualitatively different from inﬂammation in RA.
Further research is needed to clarify the role of inﬂammation, immune cells and their cytokines in the
pathogenesis of OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is one of the most common rheumatic
disorders. A majority of the elderly have radiographic or clinical
evidence of OA1. For a long time, OA was considered a non-
inﬂammatory condition and OA synovial tissue (ST) samples were
used as controls for comparative purposes in studies that focused
on rheumatoid arthritis (RA) pathogenesis. However, increasing
evidence that inﬂammation is present in ST of OA patients1e21 has
brought to light the possibility that synovitis and the immune
system could be active players in OA development and progression.to: B.J.E. de Lange-Brokaar,
dical Center, C1-45, Postbus
261425; Fax: 31-71-5266752.
ange-Brokaar).
s Research Society International. PBecause immune cells and their cytokines may play an important
role in the pathogenesis of OA and because a better understanding
of the biological mechanisms involved in this process may lead to
better therapies for OA patients, we performed a systematic
narrative review to summarize the data published thus far
regarding inﬂammation, immune cells and their cytokines in ST of
OA patients.
Methods
In cooperationwith a trained librarian, a broad search strategy in
the following databases: Pubmed (1946eSeptember 2011), Embase
(Ovid-version 1980eSeptember 2011) and Web of science (1945e
September 2011) was composed (Fig. 1). Two different search
strategies were used. The ﬁrst consisted of the AND combination of
following search terms: “osteoarthritis” and “synovium” as a majorublished by Elsevier Ltd. All rights reserved.
Fig. 1. Flowchart of ﬁrst and second (Italic) search. WoS (Web of Science).
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the AND combination of three concepts; “osteoarthritis”, “syno-
vium” and “inﬂammation” (major or minor topic). All relevant
keywords variations were used and search strategy was optimized
for all consulted databases. See Appendix 1 for literature search
details. Because the goal of this review was to summarize the
existent knowledge about immune cells and their cytokines in OA
ST, a broad search was initiated in which all studies were included
that reported data regarding immune cells or their cytokines in OA
ST, either in text or ﬁgures/tables. Moreover, studies that investi-
gated at least ﬁve OA patients were included. 32 articles that
investigated ST samples of less than ﬁve OA patients were excluded.
Only studies investigating cytokines that are commonly associated
with immune cells were included (e.g., interleukins (ILs)). Animalstudies, experiments with non-immune cells and genetic studies
were excluded. Studies concerning temporomandibular joints were
excluded. After screening full text articles and after additional hand
search of references and screening of related articles, a total of 100
articles remained.
Results
100 articles are included in this narrative review. 35 articles
investigated OA ST by standard haematoxylin and eosin (H&E)
staining (Table I). In 55 the focus was on different cell types
(Table II), and in 37 articles the focus was on cytokines (Table III).
Only scarce data are available regarding the cellular source of
cytokines in OA ST.
Table I
Studies that investigated ST in OA patients by means of H&E staining (phosphotungstic acid hematotoxylin (PTAH) and berlin blue)
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Arnoldi, 198023 OA (24*), RA (12),
N (8)
Hip arthroplasty Grading by Salvati et al., 1977 Inﬂammation moderate.
Two histological types: proliferation
and ﬁbrous form
Da, 200724 OA (41) Knee needle arthroscopy Synovial lining thickness, vascularity
and inﬁltration
Mild to moderate inﬂammatory
inﬂammation
Diaz-Torne, 200725 OA (12), RA (10),
N (9)
Knee biopsy or arthroplasty Synovitis score Krenn et al., 2002 Intermediate inﬂammation scores
Dolhain, 199626 OA (8), RA (11) Knee blind biopsy or
arthroplasty
Inﬂammation score: SLL hyperplasia
and inﬁltration
Inﬂammation score 3e8, RA 2e9
(score 0e15)
Fernandez-Madrid,
200511
OA (9) Knee arthroplasty Histology Mild chronic inﬂammation all cases
Fonseca, 200040 OA (16), RA (26) Arthroscopy Grading: LL hyperplasia, vessel
inﬁltrate þ density, ﬁbrosis,
lymphocyte clusters þ %
Mean global score (0e60) 11.1, RA 19.8
Furuzawa-Carballeda,
199919
OA (5), RA (5), N (5) Knee or hip arthroplasty Histology: degree of inﬂammation No difference between inﬁltrate type
(perivascular and interstitial) or degree
(varied moderate e abundant) between
OA and RA
Gedikoglu, 19867 OA (19) Hip arthroplasty Grading by Salvati et al., 1977 All samples had features of inﬂammation:
minimal inﬂammation 32%, moderate
53% and advanced 16%
Goldenberg, 19785 OA (17) Biopsies Grading: hyperplasia, cellular
inﬁltration and speciﬁc changes
Mostly quite normal in appearance,
few moderate synovitis. 35% MNC
inﬁltrate and 70% SLC hyperplasia
Goldenberg, 19826 OA (15), N (4) Knee or hip arthroplasty Grading: hyperplasia, cellular
inﬁltration
and speciﬁc changes
87% samples abnormal; synovitis: 40%
mild, 20% moderate, 27% markedly
inﬂamed
Haynes, 200227 OA (9) Knee arthroplasty Histology: inﬂammatory inﬁltrate 67% evidence inﬂammation,
44% large perivascular accumulations
Haywood, 200328 OA (104) Knee or hip arthroscopy
(7) or arthroplasty (97)
Inﬂammation grading 7% no inﬂammation, mild inﬂammation
28%, moderate 35% and severe 31%
Houli, 195922 OA (16) Knee biopsies Histopathological: cellular inﬁltration,
ﬁbrosis, etc
5/16 cellular inﬁltration, 11/16 ﬁbrosis,
oedema 11/16
Huss, 201029 OA (13) Arthroplasty Histology: ﬁbrin and aggregates Dense ﬁbrous bands, with aggregates
with macrophages and lymphocytes
Johnell, 198530 OA (16), RA (6) Knee or hip arthroplasty Histology: inﬂammatory cells Inﬂammatory cells around small vessels
and capillaries
Koizumi, 199931 OA (22), RA (40) Knee arthroplasty Also PTAH, berlin blue staining.
Scoring: proliferation synovial cells
and stroma (inﬁltration, etc)
Score synovitis OA 91% <10 pts, all
RA >11 pts (range 0d20 pts)
Korkusuz, 200513 OA (10), N (6) Hip or knee arthroplasty Histology: hyperplasia and
hypertrophy
SLL, ﬁbrosis
Hyperplasia and hypertrophy synovial
LL suggesting an immunogenetic role
Krenn, 200632 OA (212), RA (247),
N (49)
Knee synovectomy Synovitis score by Krenn et al., 2002 Mean values synovitis score: control
1.0 (no synovitis), OA 2.0 (low-grade),
RA 5.0 (high-grade). Signiﬁcant
differences between diagnoses and
between high- and low-grade synovitis
Loeuille, 20053 OA (39) Knee arthroscopy Grading: SLL cells, inﬁltration, surface
ﬁbrin, features vessels,
ﬁbrosis, perivascular oedema
Severe OA showed more ﬁbrin,
inﬁltrate and higher total score
than mild OA
Loeuille, 20094 OA (15) Knee arthroscopy Grading: SLL cells, inﬁltration, surface
ﬁbrin, features vessels,
ﬁbrosis, perivascular oedema
Increased number of synovial LCs,
ﬁbrosis, oedema and inﬁltration
Myers, 19902 OA (29), N (14) Knee arthroscopy Synovitis: MNC inﬁltration graded
0e3
55% Moderate or severe synovitis.
Normal ST 50% synovitis
Oehler, 200233 OA (66), RA (22),
N (8)
Arthroscopy (29) and
arthroplasty (37)
Histology: degree inﬁltration (0e4)
and hyperplasia
Four patterns: hyperplastic
(72% arthroscopy group), lymphocytic
inﬁltrates (28% arthroscopy,
arthroplasty 38%), ﬁbrotic (arthroplasty
32%), detritus rich (arthroplasty 24%)
Pearle, 200716 OA (54) Knee or hip arthroscopy
or arthroplasty
Histology: grading synovial
inﬂammation
50% Low-grade and 7% high-grade
synovitis. No differences grade between
arthroscopy and arthroplasty group
Pelletier, 1989113 OA (8) Arthroplasty Histology: morphological changes Signiﬁcant amount chroming
inﬂammation, morphological changes
were hyperplasia and hypertrophia SLC,
MNC inﬁltrate and proliferation blood
vessels
Pessler, 2008,
second34
OA (25), RA (28),
N (10)
Knee needle biopsy or
arthroplasty
Synovitis score Krenn et al., 2002,
mean (SD)
Mean synovitis score 2.23 (low-grade),
normal 1.38 (no synovitis) and RA 5.74
(high-grade)
Revell, 19889 OA (38) Knee or hip arthroscopy
(3) or arthroplasty (35)
Histology: hyperplasia, lymphoid
aggregates and ﬁbrosis
Signiﬁcantly more ﬁbrosis and lymphoid
aggregates than samples with machanical
or traumatic background.
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Table I (continued )
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Saito, 200235 OA (19) Knee arthroplasty Histology: hyperplasia, inﬁltrate
and vascular proliferation
All samples inﬁltrates and vascular
proliferation. 45% SLL thickening
Sakkas, 199836 OA (30), RA (10) Knee or hip arthroplasty Histology: hyperplasia, inﬁltrate Histology: various degree of MNC
inﬁltration, mild to moderate synovial
hyperplasia. Inﬂammatory changes
less prominent than in RA
Slansky, 201041 OA (221) RA (341) Knee synovectomy or
arthroplasty
Synovitis score Krenn et al., 2002 Median synovitis score þ/ 2 (ﬁgure),
RA 5.8 (ﬁgure), normal 0.6 (ﬁgure)
Smith, 199237 OA (8), RA (16),
N (5)
Knee arthroscopy or
arthroplasty
Histology: hyperplasia and inﬁltrate
LL and SLL
Variable LL hyperplasia as in RA. SLL:
acellular till predominantly macrophage,
lymphocyte or mixed inﬁltrates
Smith, 199718 OA (40), N (23) Knee arthroscopy (13) and
arthroplasty (27)
Histology: hyperplasia, vascularity,
cellularity and inﬁltrate
Low-grade synovitis, arthroplasty group
highest degree of cellularity, vascularity
and inﬂammatory inﬁltrate
Scanzello, 201142 OA (20) Arthroplasty and arthroscopy Inﬂammation score: perivascular
MNC inﬁltration (0e3)
25% No inﬂammation, 40% mild, 35%
moderate and no severe inﬂammation
Soren, 197838 OA (19) Knee, hip, ankle synovectomy
(8), arthroplasty (10),
arthrodesis (1)
Histology: hyperplasia and inﬁltration Some focal inﬂammatory inﬁltrates and
moderate hyperplasia
Soren, 198843 OA (74), RA (127) Knee, hip arthrotomy Histology: inﬂammatory features,
hyperaemia, oedema, haemosiderin,
ﬁbrosis, other features
Presence synovial inﬂammation features
in lesser incidence and intensity than RA
Thurkow, 199739 OA (9), RA (10) Knee needle biopsy Histology: degree inﬂammation and
inﬁltration
Inﬂammation 4.7 vs 11.4 RA
(range 0e15), little inﬁltration
N, normal.
* Number of patients.
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investigated exclusively OA ST, while the majority of the articles
used OA samples for comparative purposes. Moreover, only a few
studies compared samples of patients undergoing arthroscopy with
patients undergoing arthroplasty in OA.
Synovitis in OA
Houli et al. were among the ﬁrst to describe features of inﬂam-
mation (31% samples showed cellular inﬁltration) in ST from OA
patients22. Later, several studies conﬁrmed the presence of inﬂam-
mation in OA ST2,5e7,9,13,16,18,19,23e43. Histological features were
hyperplasia, with an increased number of lining cells (LCs) and
amixed cellular inﬁltrate2,6,7,9,18. Overall, inﬂammation of OA STwas
found to be less pronounced than in RA19,23,25e27,30e34,36,37,39, but
higher than in healthy controls13,18,19,25,32e34,37,40,41,43,44.
Synovitis score
Different scoring systems for synovitis were used throughout
the years, some designed speciﬁcally for OA16, others with focus on
RA31,45. An early scoring system of OAwas designed by Salvati et al.
for ST inﬂammatory responses in coxarthrosis7,23. In 2002 Krenn
et al. developed a scoring system for the entire spectrum of rheu-
matic diseases including OA46. This system was based on the
following morphologic alterations: hyperplasia/enlargement of
synovial LCs, activation of resident cells/synovial stroma and
inﬂammatory inﬁltration46. It is a validated scoring system that can
accurately discriminate between high and low grade synovitis32
and is frequently used21,25,34,41,44.
With this scoring system amild tomoderate synovitis was found
in OA (mean score around 2)25,32,34,44,46 vs 1.4 for healthy controls
and 5.7 for RA (scale 0e9). This mild to moderate synovitis was
conﬁrmed in other studies using author developed scoring
systems2,5e7,13,16,18,24,26,28,39. Additional histological studies
revealed that also ﬁbrosis and detritus (non-living organicmaterial)
can be seen in OA ST9,23,33,35.
Synovitis in different severity stages in OA
Tissues obtained from arthroscopy, reﬂecting early to estab-
lished disease, were usually compared with arthroplasty,reﬂecting end-stage disease. Results vary, as one study reports
a signiﬁcantly increased mononuclear cell (MNC) inﬁltration in
the arthroscopy samples17, whereas others ﬁnd these markers to
be increased in the arthroplasty samples2,3,18. Pearle et al. did not
ﬁnd difference16.
One study has extensively characterized the different inﬂam-
matory patterns and showed that hyperplasia and inﬁltrate are
characteristic for the arthroscopy group, while ﬁbrotic and detritus
rich domains together with inﬁltrate are typical for arthroplasty
group33.
Cell types found in OA ST (Table II, Fig. 2)
Many studies investigated inﬂammatory cell types in OA
ST (Table II)8e12,17,20,21,24,25,27,28,30,33e37,44,45,47e77. Several authors
reported that macrophages and T cells are the most abun-
dant cells8,9,11,17,20,21,25,34,35,37,45,47,48,51,56,57,61,62,69,78. Mast cells
(MCs)49,50,54,55,58e60,64,67,70,79, as well as B cells and plasma cells
were found, although the last two in lower amounts than other
cells9,11,21,24,25,33e35,44,45,57,69,73. Natural killer cells were detected in
OAST65 and several authors describe the presence of lownumbers of
dendritic cells (DCs)8,53,66,69. Neutrophils were almost never
found21,34,35,44,48,62. Overall OA ST contained fewer number of
inﬂammatory cells thanRAST25,30,36,37,44,45,56,57,63,65,68,69,71,75,78, but
more thannormal control ST25,34,44,45,50,51,55,57,59,61e63,65,67,70,71,75,78.
One extensive study by Pessler et al. also investigated the rela-
tive abundance of immune cells in inﬁltrates and found that
macrophages represented approximately 65%, T cells 22%, B cells 5%
and plasma cells<1% of the inﬁltrate. MCswere not analysed in this
study. Relatively more B cells were found in RA44.
Macrophages
Macrophages were mostly distributed in the lining layer
(LL)20,25,28,33,37,44,48,56,61,62,78. With increasing histological inﬁltra-
tion grade, both macrophage fraction areas as intensity of macro-
phage inﬁltration increased17,28. Subsets of macrophages,
“classically activated”(M1) and “alternatively activated”(M2)30,68,
have not been investigated in OA ST. Although the importance of
macrophages in OA ST is hypothesized21,33,35,44,48, their role in
human OA ST is still largely unknown.
Table II
Studies that investigated different cell types in ST in OA patients
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Andreu, 199147 OA (5*), RA (7) Arthroplasty MNCs isolated. Pan-g/d T cell Mab
TCR d1
No g/d T cells expansion
Benito, 200517 OA (25) Knee arthroscopy (10)
vs arthroplasty (15)
IHC Ab CD4, CD68 Signiﬁcantly more T cells and Macrophages
in arthroscopy group compared with
arthroplasty group
Bondenson, 200648 OA (19) Knee or hip arthroplasty Cell suspension ST. Flow cytometry
analysis
Mainly ﬁbroblast like synoviocytes. 2e7%
macrophages, <0.5% neutrophils, <0.1%
T Cells
Bridges, 199149 OA (42), RA (48) Knee, hip or wrist
arthroplasty or
synovectomy
Digest ST. Alcian blue staining.
Histamine release assay
In digest 1.6% MCs, not signiﬁcantly different
from RA 1.3%. Histamine content comparable
in OA and RA
Buckley, 199850 OA (14), N (14) Knee arthroplasty IHC Ab chymase spec, tryptase.
Double labelling procedure
Higher number MCs than control ST,
distributed throughout ST. OA ST shift
MCTC to MCT (77%) phenotype, normal
ST MCT (42%)
Cannons, 199851 OA (8), RA (93),
N (19)
Arthroplasty T cells isolated assay hprt-mutant
T cells, Mab CD3, CD8, TCR a/b,
TCR g/d, CD29, ﬂow cytometry
Isolated MNCs were predominantly
CD4þ T cells. Number of hprt-mutant
T cells lower than RA
Cauli, 199752 OA (10), RA (10) Unknown IHC Ab cells: 27E10, CD14, 25F9,
RM3/1. Ab cytokines: IL-1a, IL-1b,
IL-1Ra Double staining for
macrophages and cytokines
No difference subset macrophages between
LL and SLL. Higher % mature macrophages,
IL-1Raþ than IL-1aþ in SLL. % 25F9þ,
IL-1þ a cells OA <RA. % 25F9þ, IL-1Raþ
and RM3/1þ, IL-1Raþ similar OA and RA
Cauli, 200053 OA (8), RA (8) Arthroplasty IHC Ab CD1a, CD1b, CD1c Few CD1b and CD1c, no CD1a, similar to RA
Ceponis, 199879 OA (12), RA 10) Arthroplasty, arthroscopy IHC c-kit and SCF. Toluidine blue
staining
Increased densities c-kitþ synovial MCs.
Mean number c-kitþ MC/mm2 (135  26)
not signiﬁcantly different from RA (85  16)
Da, 200724 OA (41) Knee needle arthroscopy IHC Ab CD3, CD20, CD138 No B lymph inﬁltration in 54%, mild in 32%,
moderate/strong in 15% of the samples.
Plasma cells 17%. No follicular DCs
Damsgaard, 199954 OA (10) Knee or hip arthroplasty Giesma staining. Stereological
microscopy MCs
Morphology: MCs found in vicinity blood
vessels, not in LL. MCs 0.8% total number
of cell proﬁles present in ST
Diaz-Torne, 200725 OA (12), RA (10),
N (9)
Knee biopsy or arthroplasty ICH Ab CD3, CD68, CD20, CD38 Signiﬁcantly more macrophages (LL and
subintima (SI)) and T cells than gulf
war veterans illness samples.
B cells and plasma cells were sparse.
Lower number inﬂammatory cells
than in RA ST
Dean, 199355 OA (36), RA (21),
N (8)
Knee arthroscopy and
arthroplasty
Toluidine blue staining and alcian
blue safranin staining MCs
MCs most numerous in SI, number of
deregulated MCs was greater in the
superﬁcial layer. MC numbers comparable
to RA ST, higher than in control ST
Farahat, 199356 OA (10), RA (10) Arthroplasty IHC Ab CD3, CD4, CD8, CD68, CD14,
27E10, RM3/1
Macrophages predominantly in LL, T cells
mostly perivascular and in connective
tissue layer not LL. Both T cells and
macrophages in lower numbers than in RA
Fernandez-madrid11 OA (9) Arthroplasty IHC CD2, CD4, CD8, CD19, I3, RM3/1 MNC inﬁltrate composed of B and T cells,
predominantly T cells (CD4 >CD8)
Fonseca, 200257 OA (6), RA (6),
N (3)
Arthroplasty IHC and IF Ab CD68, CD163, CD14,
CD19, CD45, CD4, CD3, CD8, double
staining: IFN-g
Macrophages found in I, SI and around
lymphocytic clusters. T cells in SI. Fewer
numbers of cells than RA. Some T cells
stained for IFN-g. In normal ST no cells
stained for IFN-g
Fritz, 198458 OA (30), RA (90) Unknown Avidin-peroxidase vs toluidine blue
and Giesma staining of MCs. Double
staining method
Distribution MCs in SLL. Number of MCs
signiﬁcantly higher than in RA ST in sub
synovial layer
Gotis-Graham,
199759
OA (18), RA (16),
N (15)
Arthroscopy or
arthroplasty
IHC Ab chymase and tryptase Number MCs higher in superﬁcial layers
than in deeper layers. Number of MCs
signiﬁcantly lower than in RA ST, higher
than normal ST. Ratio MCTC:MCT 3:4, RA 3:2
Gruber, 198660 OA (7), RA (8) Unknown Histamine release studies Signiﬁcantly lower histamine content
than in RA ST
Haynes, 200227 OA (9), RA (6) Arthroplasty IHC Ab CD4, CD8, CD28, CD69, CD40L T cells major constituents of inﬁltrates.
Aggregates: CD4þ >CD8þ cells. Some
CD4þ cells were CD3. Cellular activation
marker (CD69) expressed by aggregated cells
Haywood, 200328 OA (104) Knee or hip arthroscopy
(7) or arthroscopy (97)
IHC Ab CD14, CD31. Mean macrophage
fractional area
Macrophages (LL) evident in inﬂamed
ST samples. Mean macrophage fractional
area 9.1%. Fractional area increases with
increased inﬂammation
Helbig, 198861 OA (25), RA (62) Arthroplasty Mab Ki-M6, Ki-M8, anti-HLA-DR, OKT 9 Mean HLA-DRþ similar RA. OKT9þ and
ki-M8þ cells (macrophages) lower than
in RA
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Table II (continued )
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Hogg, 198562 OA (8), RA (9) Arthroplasty,
arthroscopy
Mab 24, UCHM1, 44, 24, DA2, 5.5, 28 Less mature monocyte in intima,
macrophages scattered intima,
HLA-D-positive cells were synovial
monocytes. Subset synovial cells was
densly stained by monoclonal antibody
5.5 No neutrophils
Ishii, 200263 OA (10), RA (10),
N (10)
Arthroplasty IHC Ab CD3, CD4, CD8 More CD3þ and CD4þ positive T cells
than normal ST, but less than in RA ST.
T cells found in SLL and DL, RA in all
ST layers
Johnell, 198530 OA (16), RA (6) Knee or Hip arthroplasty IHC Ab leu-1, 2a, 3a cells Leu-1 T cells and Leu-3a, leu-2a sparse.
Leu-3a near HLA-DRþ cells. T cells RA
ST >OA ST
Kraan, 199945 OA (17), RA (36),
N (5)
Knee needle biopsy IHC Ab CD3, CD4, CD8, CD68, CD22,
CD38, CD55
Mostly T cells (CD4þ >CD8þ) and
macrophages, few B cells and plasma
cells. Lower number of cells than RA ST,
more than normal ST
Kopicky-Burd,
198864
OA (22), RA (19) Arthroplasty Histology MCs, histamine content
perchloric acid extraction
MCs in SI often in perivascular locations.
Histamine content not signiﬁcantly
different (OA 5.4, RA 3.7)
Kummer, 199465 OA (5), RA (5) Knee Arthroplasty and
arthroscopy
Mab granzymes A and B. IHC double
staining UCHT1, MT310, DK25, CD3,
CD4, CD8, CD16, CD56, CD15
2/5 samples OA granzyme A and B,
3/5 in RA, granzyme A and B positive
cells mostly CD16þ, CD56þ NK cells
Lebre, 200866 OA (10), RA (20) Arthroscopy IHC Ab CD1c, CD304, CD3, CD8, CD11c,
CD123
Both myeloid DCs and plasmacytoid
DCs were observed in low numbers,
mostly in SLL
Lindblad, 19878 OA (10) Knee arthroscopy IHC Ab aLeu-1, aLeu-4, aLeu-2a, aLeu-3a,
OKM1. Double staining with HLA-DR
All cell types, but mostly macrophages
and T cells (predominantly T-helper
phenotype) were found. HLA-DRþ cells
near aLeu-3a
Lindblad, 198910 OA (5) Knee arthroscopy IHC Ab aLeu-1, aLeu-4, aLeu-2a, aLeu-3a,
OKM1. Double staining with HLA-DR
Local inﬂammation with T cells, B cells,
plasma cells and HLA-DR-expressing
DCs adjacent to CD4þ T-helper cells
Mitchell, 200878 OA (10), RA (14),
N (6)
Knee arthroplasty IHC CD68þ Lower number macrophages than in
RA ST, more than in normal ST
Nakamura, 199912 OA (5) Arthroplasty IHC Ab CD3þ Mild or moderate inﬁltration of CD3þ
T Cells observed in all samples in mainly
perivascular areas
Nakano, 200767 OA (12), RA (14),
N (4)
Knee arthroplasty Supernatants ST. Western blot and IHC
Ab tryptase
MC tryptase activity similar in OA and RA,
sign. higher than in control ST
Oehler, 200233 OA (66), RA (22),
N (8)
Arthroscopy (29) and
arthroplasty (37)
ICH Ab CD3, CD4, CD8, CD20, CD68 and
CD138
In ST with histological inﬂammatory
features more B cells, T cells and plasma
cells, compared with other histological
patterns. More macrophages in lining
LL than in RA ST or normal ST
Ogdie, 201021 OA (31), RA (28),
N (22)
Knee needle biopsy,
arthroscopy and
arthroplasty
IHC Ab CD3, CD15, CD38, CD20, CD68 Mostly T cells and macrophages, in LL.
Little B cells and plasma cells and
neutrophils. Intermediate cell densities
in OA ST. CD68 distinguishes OA from
RA and normal
Pawlowska, 200968 OA (11), RA (11) Knee synovectomy and
hip arthroplasty
T cell population. FACS. Ab CD3, CD4.
CD8, CD28
Lower number T cells than in RA ST,
CD4þ >CD8þ cells. Relatively more
CD28þ cells in older people, not sign
Pelletier, 1989113 OA (8) Arthroplasty Immunostaining studies. PAb human
IL-1 (a and b)
Signiﬁcant amount chronic inﬂammation.
Signiﬁcant amount IL-1 in MNC inﬁltrate
SLL and at LL level
Pessler, 2008, ﬁrst44 OA (25), RA (25),
N (15)
Knee needle biopsies or
arthroplasty
ICH Ab, CD3, CD20, CD38,
CD68. Quantitative assessment (QA)
and relative composition inﬁltrate (RC)
Mostly macrophages in LL and SI (RC  65%)
and T cells in SI (RC  22% (40% CD8þ)),
no/few neutrophils and B cells and plasma
cells in SI (RC  5% B cells, plasma
cells <1%). RC similar normal ST, RA more
CD20, CD38þ, less CD68þ
Pessler, 2008,
second34
OA (25), RA (28),
N (10)
Knee needle biopsies or
arthroplasty
ICH Ab CD15, CD3, CD8, CD20, CD38,
CD68. Quantitative assessments (QA)
QA: macrophages and T cells most common
cells. Numbers lower than RA and higher
than normal. Little B cells and plasma cells
in OA ST
Pettit, 200169 OA (10), RA (18), Knee arthroplasty IHC Ab C-19, (Rel-B), CD-20, CD3,
CD68, HLA-DR
Perivascular MNC aggregates were small
and few. Some had nRelBþ differentiated
DCs, B cells, T cells and macrophages,
84% lacked nRelBþ diff DCs
Pu, 199870 OA (13), RA (17),
N (3)
Knee arthroplasty Prussian blue staining MCs MCs found near small blood vessels. MC
count signiﬁcantly higher than in RA ST
and normal ST
(continued on next page)
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Table II (continued )
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Revell, 19889 OA (38) Knee, hip arthroscopy
(3), arthroplasty (35)
IHC Ab 24, 44, OKM1, 10.1, OKT4,
OKT8, Pan B, 52, 29
Macrophages found in most samples at
different locations, T cells 50% samples
in SLL (OKT4þ >OKT8þ), few pan B cells
Rollin, 200871 OA (19), RA (11),
N (3)
Knee arthroplasty Flow cytometry CD5þ, CD69þ IHC
(OA n ¼ 9, RA n ¼ 6) Ab CD5, CD69
Tendency to higher expression lymphocytes
than normal ST, lower than RA ST.
Lymphocyte recent activation phenotype
comparable RA ST and signiﬁcantly higher
than normal ST
Saito, 200235 OA (19) Knee arthroplasty IHC Ab CD68, CD2, CD4, CD8, CD15,
CD19, CD25, CD1a, toluidine blue for
MC (n ¼ 11)
Mostly T cells (CD4þ> CD8þ) and
macrophages. 45% samples MCs in vicinity
blood vessels. Macrophage/helper T cell
interaction might be involved in synovitis
in OA
Sakkas, 199836 OA (30), RA (13) Knee or hip arthroplasty IHC Ab CD3, CD69, CD25, CD45RO,
HLAII, CD38, CD43
65% samples lymphoid cells aggregates,
containing predominantly CD3þ T cells.
Expression of activation antigens,
although in fewer numbers than in RA ST
Sakkas, 200472 OA (19), RA (9),
N (9)
Arthroplasty Digested ST. Flow cytometry, IF, FACS
and IHC. Ab anti-CD3z, anti-CD3ε
Decreased CD3z protein relative to CD3ε.
Suggests chronic T cells stimulation and
conﬁrms T cell involvement in OA
Scanzello, 200920 OA (11) Knee arthroscopy (4) and
arthroplasty (7)
IHC Ab CD3, CD8, CD68 Macrophages two distributions: in LL and
scattered throughout SLL (similar in both
groups) and lymphocytic accumulations
(all arthroscopy samples, 57% arthroplasty
samples)
Shiokawa, 200173 OA (6) Knee arthroplasty Reverse transcriptase-PCR B-cell
clonotypes DNA-cloning and
sequencing
Inﬁltrating B-cells are oligoclonal
(antigen-driven immune response may
play a part in disease progress OA)
Smith, 199237 OA (8), RA (16),
N (5)
Knee arthroscopy or
arthroplasty
IHC Ab CD3, CD8, CD4, IL-2r, CD25,
CD5, CD14, CD64, CD11c
Mostly T cells (SLL) and macrophages (LL).
IHC changes in similar as in RA ST,
suggesting quantitative rather than
qualitative differences
Steiner, 199974 OA (5), RA (8) Knee arthroplasty IHC Ab CD3, CD4, CD8, CD20, CD45RA,
CD45RO, CD68, IL-2, IL-4, IL-6, IFN-g,
TNF-a, double staining
80% samples only a few T cells, 20%
had more T cells. CD4:CD8 ratio comparable
to RA ST. No T cell cytokine expression in
OA could be found
Warren, 199175 OA (7), RA (8) Arthroplasty or
synovectomy
IHC CD3, CD4, CD8, CD45, CD45RA,
CD45RO
Little lymphoid inﬁltrate
Weidler, 200476 OA (8), RA (9) Arthroplasty mAB CD3, CD163, CD1a, CD1b, CD1c Lower number of all investigated cells
than in RA ST
Yamada, 201184 OA (12), RA (18) Arthroplasty Isolation MNC, FACS IL-17A, CD57,
CD45RO, CD28, IFN-g, CD4, HLA-DR,
CD69, CCR5 and intracellular staining
CD 4 T Cells expressed activation markers
higher level than RA T cells. Th1 (IFN-g)
cells predominate in both OA as RA ST.
Th17 (double producers IFN-g and IL-17)
were scarcely found
Yudoh, 200077 OA (18), RA (25) Arthroplasty or
synovectomy
Lymphocytes isolated. Intracellular
staining. FACS. Ab IL-4, IFN-g, IL-2,
IL-10, subtyping T cells by production
cytokines
TH1 (IFN-g, no IL-4) /TH2 (IL-4, no IFN-g)
ratio 1.5, 6.1 in RA. Tr1 (IL-10, no IL2 and
no IL-4), thought to inhibit Th1-respons,
higher than in RA ST. Other subsets
CD4þ comparable RA
N, normal; diff, diffuse; IF, immunoﬂuorescence; Ab, anti-bodies.
* Number of patients.
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T cells were predominantly detected in the sublining layer (SLL)
and to some extent in the deep layer (DL)9,12,37,44,56,57,63. T cells
expressing activation antigens were found by different
authors27,36,72. Sakkas et al. found that the MNC inﬁltrate consisted
of T cells expressing early (cluster of differation (CD)69), interme-
diate (CD25 and CD38) and late (CD45RO human leukocyte antigen
(HLA) class II) activation antigens in OA ST36. A later study by the
same author showed a decrease in CD3z protein in OA ST, which is
suggestive for a chronic T cell stimulation72. An altered ratio of CD4/
CD8 T cells was found, showing a relative enrichment of CD4þ T
cells9,11,27,35,44,45,68,74. Saito et al. reported a CD4þ/CD8þ ratio in OA
ST of 5:1, compared to normal ST, where the ratio is 2:135. Steiner
et al. found that the CD4þ/CD8þ ratio in OA ST was comparable to
RA ST74. Benito et al. reported that the abundance of CD4þ T cells
was signiﬁcantly greater in OA ST of the arthroscopy group
compared to the arthroplasty group17.Several populations of T helper (Th) cells can be distinguished:
Th1, Th2 and Th17 as well as regulatory cells (Th3 and Tr1) with
unique function and unique cytokine patterns (Fig. 2)80e83.
Different types of Th cells have been identiﬁed in OA ST, based on
their cytokine proﬁle upon in vitro activation. The Th1/Th2 cell
ratio in OA reported by Yudoh et al. was 1.5 compared with 6.1 in
RA77. Th1 cell was seen more frequently than Th17 cells84. One
study by Yudoh et al. has investigated the presence of Tr1,
a regulatory T cell that inhibits immune responses, in OA. The
authors describe a higher abundance of Tr1 cells in OA ST
compared to RA ST77. Moreover, several authors favour the
concept that T cells play an important part in pathogenesis of
OA8,12,18,36,63,72,85.
MCs
Different authors detected MCs in OA ST35,49,50,54,55,58e60,64,67,70.
Bridges et al. reported a percentage of 1.6 in OA ST49. Buckley et al.
Table III
Studies that investigated cytokines in ST in OA patients
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Alanärä, 201092 OA (10*), RA (10) Arthroplasty Total RNA extraction, RT-PCR IL-10,
IL-19, IL-20, IL-22, IL-24, IL-26
IL-10 and IL-26 expression similar as in RA,
IL-19 lower than in RA ST. no IL-20 and
IL-22 in OA
Brentano, 200998 OA (8), RA (9) Synovectomy or
arthroplasty
IHC Ab IL-23 subsets p19 and p40.
Total RNA extraction. RT-PCR
IL-23p19 and IL-23p40
No/little IL-23 subsets. Subunits IL-23p19
and IL-23p40 not or weakly
Benito, 200517 OA (25) Knee arthroscopy (10)
vs arthroplasty (15)
IHC Ab TNF-a, IL-1b TNF-a and IL-1b expression signiﬁcantly
increased in arthroscopy group compared
with arthroplasty group
Brenner, 200487 OA (41) Arthroscopy RNA ST isolation, RT-PCR IL-6,
IL-1b, IL-1a, TNF-a
No TNF-a or IL-1a. IL-1b in 14 of 16 investigated
samples and IL-6 in all 17 samples
Cauli, 199752 OA (10), RA (10) Unknown Ab cytokines: IL-1a, IL-1b, IL-1Ra
Double staining for macrophages
and cytokines
% 25F9þ, IL-1Raþ higher than IL-1aþ in SLL., IL-1þ
a macrophages OA <RA. % 25F9þ, IL-1Raþ and
RM3/1þ, IL-1Raþ similar OA and RA
Chu, 199199 OA (8), RA (18),
N (7)
Arthroscopy IHC Ab TGF-b1 TGF-b1 detected, although in reduced quantities
than in RA
Deleuran, 1992107 OA (8), RA (18) Knee arthroplasty
and arthroscopy
IHC IL-1a, IL-1R1, IL-1Ra Fewer IL-1a and IL-1R1 in interstitium compare
with RA. Similar percentage IL-1a in LL. Staining
intensity IL-1a lower than in RA. IL-1Ra mostly
LL as in RA
Deleuran, 199493 OA (11), RA (13),
N (6)
Arthroplasty IHC and IF Ab IL-8 IL-8 LL and in deeper layers around vessels.
Numbers signiﬁcantly higher than normal ST,
lower than RA ST (not signiﬁcant)
Dolhain, 199626 OA (8), RA (11) Knee blind biopsy
or arthroplasty
IHC Ab IFN-g and IFN-gR IFN-gþ cells in 88% samples and IFN-gR in 38%
samples, mainly around blood vessels and SL.
Number cells lower than in RA
Doss, 200788 OA (49) Knee or hip
arthroplasty
IHC Ab IL-6 counterstaining for
different cells
Plenty IL-6 cells in synovial LL. Counterstaining
revealed IL-6 production by plasma cells
Farahat, 199356 OA (10), RA (10) Arthroplasty IHC Ab IL-1a, IL-1b, IL-6, TNF-a,
GM-CSF
Expression IL-1a, IL-1b, IL-6, TNF-a, GM-CSF.
Intensities expressions signiﬁcantly lower than
in RA ST. Differences in cytokine production
OA and RA quantitative, not qualitative
Fonseca, 200257 OA (6), RA (6),
N (3)
Arthroplasty IHC, IF Ab CD68, CD163, CD14, CD19,
CD45, CD4, CD3, CD8, double staining:
IFN-g
Some T cells stained for IFN-g. In normal ST
no cells stained for IFN-g
Furuzawa-Carballeda,
199919
OA (5), RA (5),
N (5)
Knee or hip
arthroplasty
IHC Ab IL-8, IL-10. Total extracted
RNA. RT-PCR IL-1b, TNF-a, IL-4, IL-6,
IL-8, IL-10, IL-13, and TGF-b1
Little IL-8 and IL-10 expression, lower than
RA ST, higher than normal ST. RT-PCR IL-1b,
TNF-a, IL-6, IL-8, IL-10, and TGF-b1
Gracie, 1999100 OA (7), RA (18) Arthroplasty IHC Ab IL-18. Total RNA extraction
OA (10), RA (20), RT-PCR IL-18
Little IL-18 compared to RA ST. IL-18 detected
in OA ST by RT-PCR
Heinhuis, 201194 OA (9), RA (15) Arthroplasty Total mRNA extraction. RT-PCR
isoforms IL-32a, IL-32b, IL-32g
and IL-32d
All isoforms detected IL-32 in OA. IL-32 g
signiﬁcantly lower than in RA ST
Hulejova, 200789 OA (55), N (10) Hip arthroplasty Tissue extracts OA ST. ELISA.
Ab IL-1a, IL-10, IL-8, TNFa
IL-8 and IL-10 signiﬁcantly higher than normal
ST, TNF-a and IL-1a comparable to normal ST
Ishii, 200263 OA (10), RA (10),
N (10)
Arthroplasty IHC Ab IL-4 and IFN-g IFN-gþ ﬁve-fold higher than IL-4þ cells. Number
both cells  three-fold lower than in RA. Normal
ST no IFN-g and IL-4 staining
Jungel, 2004106 OA (6), RA (12) Synovectomy or
arthroplasty
IHC Ab IL-21R and IL-21 total
RNA extraction. RT-PCR IL-21
and IL-21R
Weak IL-21R expression 33% samples. No IL21
in RA and OA ST. No IL-21 and IL-21R
expression by RT-PCR
Kohno, 200895 OA (10), RA (11) Arthroplasty cDNA samples RT-PCR IL-17 IL-17 gene not different from RA
Kragstrup, 2008101 OA (5), RA (8) Arthroplasty IHC Ab IL-20 and IL-24. Total RNA
extraction, RT-PCR IL-20, IL-24
and TNF-a
Only few IL-20 positive cells. IL-24 staining
present but weaker than in RA ST, with discreet
staining of endothelial cells. IL-20 and IL-24
expression PRC same RA ST
Melchiorri, 1998102 OA (18), RA (6) Knee arthroscopy IHC Ab IL-1b, TNF-a IL-1b and TNF-a expression mostly in LL and
less in SLL. Expression both cytokines lower
than in RA ST
Ning, 201190 OA (23) Knee replacement
surgery (19),
arthroscopy (4)
IHC Ab IL1b, TGF-b. Comparison
K/L 2 or 3 vs K/L 4
IL-1b expression in both LL and SLL, higher
expression in patients with K/L 2or 3 than in
patients with K/L 4, TGF-b higher in K/L 4 than
in patients with K/L 2 or 3
Saha, 1999108 OA (6), N (7) Knee arthroplasty In situ hybridization and IHC ICE Expression IL-1b-converting enzyme (ICE) was
detected in OA ST
Sakkas, 199885 OA (16), RA (10) Arthroplasty or
synovectomy
IHC Ab IL-12p40, IL-12p70,
counterstaining Ab CD68, CD20.
RNA extraction. RT-PCR IL-12p40
31% samples IL-12p70þ cells (synovial LCs and
monocyte/macrophages), no IL-12p40þ.
Presence IL-12p70 suggests an immunoregulatory
role for IL-12. IL-12p40 transcripts detected,
lower than in RA ST
(continued on next page)
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Table III (continued )
Author Arthropaties OA phenotype Methods Results/conclusion OA ST
Scanzello, 200920 OA (11) Knee arthroscopy (4)
and arthroplasty (7)
IHC Ab rec-IL-15. Total RNA
extraction. RT-PCR IL-1b, TNF-a,
IL-2, IL-6 IL-15 and IL-21
Rec-IL-15 staining in LL and endothelium.
IL-1b, TNF-a, IL-6 and IL-15 similar groups.
IL-21 sign higher in arthroplasty group.
IL-2 detectable over half patients
Shao, 2009103 OA (8), RA (12),
N (7)
Unknown Western blot IL-18, IL-18R, IL18BP.
Total RNA extraction. RT-PCR IL-18,
IL-18R and IL-18BP
IL-18 and IL-18R expression higher than control,
lower than RA ST. Lower IL-18 and IL-18R than
RA ST, higher N ST. Higher IL-18BP than RA ST,
lower than N ST
Smith, 199718 OA (40), N (13) Knee arthroscopy (13)
and arthroplasty (27)
IHC Ab IL-1a, IL-1b, IL-1Ra, TNF-a In arthroplasty group higher production IL-1a, IL-1b
and TNF-a than arthroscopy group. Similar IL-1Ra
expression between OA groups and normal ST
Steiner, 199974 OA (5), RA (8) Knee arthroplasty IHC: Ab IL-2, IL-4, IL-6, IFN-g,
double staining method
No T cell cytokine expression could be found
Suzuki, 200696 OA (12), RA (21) Arthroplasty Total RNA extraction. RT-PCR TNF-a TNF-a gene signiﬁcantly higher in OA compared
with RA
Szekanecz, 1995104 OA (10), RA (10),
N (4)
Arthroplasty IHC Ab TGFb1, CD11c, f VIII
H&E staining combined with IHC
Little TGF-b1 expression by LCs, macrophages
and endothelial cells, less than RA ST, more
than normal ST
Tanaka, 2001105 OA (12), RA (24) Arthroplasty IHC IL-18, western blot IL-18
(RA ¼ 10, OA ¼ 6) total RNA
extraction. RT-PCR IL-18, IL-18R,
IL-18Rb
Small number IL-18 positive cells SLL lower
than RA. All samples pro-IL-18, 67% no/weakly
mature IL-18. IL-18 mRNA two of four samples.
No IL-18R and IL-18Rb.
Thurkow, 199739 OA (9), RA (10) Knee needle biopsy IHC IL-15 Ab Little IL-15 expression compared with RA
Wagner, 199797 OA (5), RA (14) Arthroplasty,
synovectomy
Total RNA extraction, RT-PCR
IL-1b, TNF-a, IL-2, IL-4, IL-5,
IL-6 and IL-10
Expression IL-1b, TNF-a, IL-6 and IL-10 detected,
expression IL-2, IL-4 and IL-5 not detected
Warren, 199175 OA (7), RA (8) Arthroplasty or
synovectomy
IHC IL-2. Total RNA extraction,
PRC IL-2
IHC: no IL-2 staining. mRNA IL-2 not increased
above background
Wassilew, 201091 OA (12) Arthroplasty RNA extraction, RT-PCR IL-1b,
TNF-a
Both IL-1b and TNF-a found in ST. No differences
between OA and traumatic joint disorder samples
Yamada, 201184 OA (12), RA (18) Arthroplasty Isolation MNC, FACS IL-17A,
CD57, CD45RO, CD28, IFN-g,
CD4, HLA-DR, CD69, CCR5 and
intracellular staining
CD 4 T Cells expressed activation markers higher
level than RA T cells. Th1 (IFN-g) cells predominate
in both OA as RA ST. Th17 (double producers
IFN-g and IL-17) were scarcely found
Yudoh, 200077 OA (18), RA (25) Arthroplasty or
synovectomy
Lymphocytes isolated. Intracellular
staining. FACS. Ab IL-4, IFN-\g,
IL-2, IL-10
TH1 (IFN-g, no IL-4) /TH2 (IL-4, no IFN-g) ratio
1.5, 6.1 in RA. Tr1 (IL-10, no IL2 and no IL-4)
higher than in RA ST
N, normal; IF, immunoﬂuorescence; Ab, anti-bodies.
* Number of patients.
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in amputation controls50. Overall MC numbers were as
high49,50,55,79 or higher58,70 compared to RA and higher than in
controls50,55,59,67,70,79, although one study reported lower numbers
of MCs in OA compared to RA59. The highest abundance of MCs was
found within the SLL54,55,58,59 and around blood vessels54. The
number of degranulatedMCs was highest in superﬁcial layers of OA
ST, indicating their active state. In RA ST the number of MCs was
highest in the capsule55. Despite a common origin, similar granu-
lated morphology and functions, MCs are a heterogeneous group ofFig. 2. T cells and T cell subsets in OA, with most important cytokines. Th cells (Th1, Th2, acells. MCs can be subdivided into MCs containing only tryptase
(MCT) and in MC containing both tryptase and chymase (MCTC) as
deﬁned by Irani et al.86. Buckley et al. investigated the MC
subpopulations in OA ST vs control subjects. They found a striking
shift in the relative proportions of MCs with a MCTC phenotype to
MCs with a MCT phenotype. The number of MCs with a MCT
phenotypewas higher in OA ST (median 53MCT/mm2) than in post-
mortem control ST (7.5 MCT/mm2) or amputation controls (12 MCT/
mm2)50. Gotis-Graham et al. reported a lower ratio of MCTC/MCT in
OA than in RA ST (3:4 vs 3:2)59. Similarly, a higher tryptase activitynd Th17), T regulatory (Treg) cells and induced T regulatory (iTreg) cells (Th3 and Tr1).
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histamine content of MCs was the same or higher in OA ST than in
RA ST49 whereas a lower histamine release is reported60,64.
B cells
Although present in low numbers, B cells and plasma cells were
detected in OA ST8,9,11,29,34,35,44. However, their relative abundance is
lower than in RA44. Da et al. reported that OA ST with increased
inﬂammatory inﬁltrate contained relatively more B cells. Moreover,
inﬁltrated B cells in ST of patients with OA were shown to be oligo-
clonal, suggesting an antigen-driven expansion73. Supporting this
observation sequencing of the complementarity determing region
(CDR) regions of these cells indicated that B cells have been clonally
expanded. Therefore, a role for these cells during the course of OA
cannot be excluded24.
Other cells
Natural killer cells were not frequently studied but have been
detected in OA ST65. Additionally very few DCs were seen in OA
ST8,53,66,69, although both plasmacytoid DC and myeloid DC subsets
were found66.Cytokines associated with immune cells found in OA ST (Table III)
Although cytokines were extensively studied in animal and
experimental studies, and in synovial ﬂuid from OA patients,
studies that primary focus on cytokines in OA ST are less abun-
dant17,18,20,87e91. Various cytokines associated with immune cells
have been detected in OA ST17e20,26,39,52,56,57,63,75,85,88e105, and only
a few studies reported no cytokine expression at all74,106.
Cytokines detected in OA ST
IL-1b and tumour necrosis factor alpha (TNF-a) are both pro-
inﬂammatory cytokines and are most frequently studied and
detected17e20,52,56,87,89e91,97,102,107. These cytokines were most
frequently seen in LL52,102,107 and to a lesser amount in SLL52,90,102.
Moreover, the presence of IL-1b-converting enzyme (ICE) indicates
that IL-1b is not only present in OA ST, but that it can also be
activated108. However, their cellular source is still largely unclear.
Only one study used a double staining method for IL-1 and
macrophage markers. In this study, macrophages were found
positive for IL-1 and IL-1Ra.
Likewise, several other pro- and anti-inﬂammatory cytokines
have been investigated in OA19,20,26,39,56,57,63,74,75,77,85,87e90,92e95,97e
101,103e106. Among these, interferon gamma (IFN-g), IL-2, IL-4, IL-6,
IL-8, IL-18, transforming growth factor (TGF)-b and IL-10 have
received most attention.
IFN-g was detected by means of immunohistochemistry
(IHC)26,57,63. The cellular origin of IFN-g remains unclear. Although
Yudoh et al. showed that ST T cells in OA can produce IFN-g when
stimulated ex vivo77. IHC studies using counterstaining for CD3
showed only very little57 or no IFNg-positive T cells in situ74. These
data indicate that IFNg-producingTcellsmightnot be activated invivo
and that other cells could be the main source of this cytokine in OA.
IL-10 and IL-4 were also found in OA ST19,63,77,89. Yudoh et al.
showed that ST T cells in OA can produce IL-10 and IL-4 when
stimulated ex vivo77. Similarly to IFNg, however, IHC using coun-
terstaining for CD3 did not detect T cells positive for IL-4, indicating
that T cells might not be the source of IL-4 in OA ST74. The cellular
source of IL-10 has not been investigated yet.
Ex vivo stimulated T cells from OA ST were also found to produce
IL-277, although this cytokine could not be detected bymeans of IHC
in ST74,97. In conclusion, the cytokines secreted by ST T cells in OA
are still unknown.IL-6 has been detected in OA ST19,56,88. In the largest study by
Doss et al., IL-6 was detected in LL88. Stainings for various cellular
markers indicated that plasma cells are the main source of IL-688.
Another cytokine associated with innate immunity, IL-8 was
found to be produced in OA ST by means of IHC and enzyme linked
immuno sorbent assay (ELISA) by several authors19,89,93. Deleuran
et al. found IL-8 in OA samples predominantly in deeper layers and
around vessels93. However, the cellular source of IL-8 remains
unclear.
IL-18 and its precursor forms were also detected in several
studies100,103,105 and IL-18-producing cells were found predomi-
nantly in the SLL105.
Finally, several studies found the presence of TGF-b in OA
ST90,99,104. By means of H&E staining combined with IHC, it was
found that macrophages were the primary immune cells express-
ing TGF-b104.
For most of the cytokines described above, messenger
Ribonucleic acid (mRNA) transcripts were also detec-
ted19,20,75,85,87,91,92,94,96e98,100,101,103,105,106. Additionally, some cyto-
kines have only been investigated by means of mRNA analysis. Of
those, IL-5, IL-13, IL-17, IL-19, IL-21, IL-26 and IL-3219,20,92,94,95,97
could be detected, whereas IL-22 could not be detected in OA ST92.
Differences in cytokine proﬁles between arthropaties
The overall conclusion emerging from the above-mentioned
studies is that differences in cytokine expression between OA and
RA are mainly quantitative, not qualitative19,56. In general, the
number of cytokine-positive cells was lower in OA ST than in
RA19,26,39,56,63,74,89,93,98e105 and higher than in normal
ST18,19,51,57,63,93,103,104, indicating that OA is characterized by less
inﬂammation than RA. Only one study found similar TNF-a and
IL-1a expression in OA ST compared with normal ST89.
Cytokine proﬁles in different severity stages in OA
Inﬂammation is believed to play a role in OA severity and
progression. However, only very few studies exist that compare
inﬂammation with different severity stages in OA. Moreover, only
few cytokines were investigated in these studies. Moreover, con-
ﬂicting ﬁndings exist in expression of IL-1 and TNF-a between ST of
patients undergoing arthroscopy and patients undergoing arthro-
plasty. Benito et al. found a higher expression of both cytokines in
the arthroscopy group, which is supported by results by Ning et al.
The latter reported a higher IL-1b expression in patients with less
severe disease (KellgreneLawrence score 2 and 3 vs 4). In the same
study TGF-b expression was found to be lower in patients with less
severe disease90. In contrast Smith et al. reported higher expression
of IL-1a, IL-1b and TNF-a in the arthroplasty group18, suggesting
that additional studies are necessary for a ﬁrm conclusion.
Discussion
In this review we aimed at summarizing the published data
regarding the presence and phenotype of immune cells and their
cytokines in ST of OA patients. Our analyses revealed that synovitis
is a common feature of OA and is usually characterized by the
presence of inﬁltrating immune cells, such as macrophages, T cells
and MCs. Likewise, among the cytokines investigated, the pro-
inﬂammatory cytokines TNFa and IL-1b were most frequently
detected in OA ST. Based on our analyses, we will discuss the
limitations of our study, as well as possible research directions that
could facilitate understanding the role of the immune system in OA.
Our search revealed that over 100 studies investigated and re-
ported data on ST in relation with inﬂammatory markers. Because
we intended to give a comprehensive overview of the literature, we
included all studies in which more than ﬁve OA patients
Table IV
Research agenda for future investigations of ST in OA patients
Research agenda
 To investigate severity and histological features at different OA severity
stages
 To correlate histological synovial inﬂammation severity and histological
features with clinical parameters (pain/function)
 To investigate course/persistence of synovial inﬂammation during OA disease
course in longitudinal studies
 To investigate the role of synovial inﬂammation in disease progression in
longitudinal studies
 To further investigate cellular source of cytokines in ST of (different stages)
OA patients
 To further investigate different subtypes of cells in ST of (different stages) OA
patients
 To investigate presence of cells and cytokines in relation to disease severity
and clinical features (pain/function) in (different stages) OA patients
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number of patients, however, implies that some of the presented
data needs conﬁrmation in additional studies or in larger cohorts. A
meta-analysis of the studies was unfortunately not feasible, due to
differences in methods and outcome measurements (e.g., different
semi-quantitative systems and quantitative measures (IHC cells/
mm2 or cells/hpf or % inﬁltrate, % total ST)). Development of stan-
dardized methods for evaluating synovial inﬂammation could
therefore be beneﬁcial in the future.
Another limitation of the studies published thus far is that,
while the knee is the most investigated joint (68% of articles that
reported joint site), several studies exist that investigated both
knee and hip but combined the data instead of presenting them
separately. This complicates the interpretation of the results, as it is
currently unclear how similar STs from different anatomical posi-
tions are in OA. It is likely that differences will be present, due to
different inﬂuences from neighbouring organs, such as the infra-
patellar fat pad (IFP) in the knee, which is lacking in the hip.We and
others have previously shown that the IFP is a source of inﬂam-
matory mediators and could inﬂuence the pathophysiological
processes in the knee joint109e111. Comparative studies of different
ST would be of great interest for our understanding of the disease.
One of the most important conclusions of our review is that
inﬂammation and synovitis are present in OA ST. More importantly,
the features found by IHC seem to correlate with the inﬂammation
observed bymagnetic resonance imaging (MRI) Several histological
features of ST (except oedema) and total composition score were
signiﬁcantly correlated (little-moderate) with MRI synovitis grade.
Much less is known, however, on the correlation between
inﬂammation and clinical characteristics. In a study in 39 OA
patients both function and pain were not associated with macro-
scopic and microscopic parameters of ST, visualized by H&E stain-
ing3. Because this is the only study that investigated correlation
between clinical symptoms and ST, it remains largely unknown
how features of OA ST translate to signs and symptom of OA in
patients. Addressing this question in future studies will likely
constitute a considerable step forwards to a better understanding
and potentially treatment of OA patients.
The role of the immune system and of cytokines in OA is still
poorly understood. Although several studies have shown the pres-
ence of different immune cells in ST in patients with OA, only few
have attempted to further characterize these cells phenotypically
and functionally. For example, it is still unclear which cytokines are
secreted by macrophages, T cells and MCs, the most abundant
immune cell populations in OA ST. Moreover, it is unclear how their
phenotype relates to clinical symptoms or radiological features.
Pain is one of the most important features of clinical OA.
Although the biological mechanisms involved in pain are still
largely unclear, it has been suggested that local inﬂammation could
play an important role16. This hypothesis is also supported by the
ﬁnding that TNF-a concentration in synovial ﬂuid was found to
correlate with pain in knee OA patients112.
In conclusion, more detailed knowledge of the immune cells and
their cytokines in synovitis is important for a better understanding
of clinical features in OA, including pain.
Comparison between OA and other arthritides or between
different clinical phases of OA (early and late) could also offer insight
into the role of synovial inﬂammation in disease progression. Several
studies summarized in this analysis have addressed this topic.
Unfortunately, the data are contradictory probably due to different
deﬁnitions used for “early” or “late” OA; some authors found syno-
vitis and cytokine expression more pronounced in patients with
“late” OA undergoing arthroplasty2,3,18, others declared the oppo-
site17,90 or did not ﬁnd difference16. Longitudinal studies in different
OA populations might offer a more deﬁnite conclusion.Studies comparing OA with RA point largely to the same direc-
tion; the number of inﬁltrating immune cells as well as the
expression of cytokines were higher in RA than in OA ST and both
were higher than in normal ST. This is in line with the clinical
observations that OA is less inﬂammatory than RA. However, there
is one population of immune cells that is enriched in OA compared
to RA, namely MCs. This indicates that the inﬂammation in OA may
be less than in RA, but could be qualitatively different. This
intriguing ﬁnding was conﬁrmed by several studies and point to
MCs as potentially important players in synovitis in OA. Future
studies are needed to elucidate the role of MCs in OA.
In conclusion, our study indicates that inﬂammation is
commonly detectable in OA ST and is characterized by immune cell
inﬁltration and cytokine secretion. This inﬂammation seems in
some aspects qualitatively different from the inﬂammation in RA.
Future studies are needed to elucidate the role of different immune
cells types and their cytokines in the development and progression
of OA and their associationwith the different clinical features of the
disease. Based on our results we suggest the research agenda
depicted in Table IV.
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references
Number of unique
references
PubMed 1. ("osteoarthritis"[Majr] OR osteoarthritis[ti] OR osteoarthritic[ti]
OR Osteoarthritides[ti] OR Osteoarthrosis[ti] OR Osteoarthroses[ti]
OR "Degenerative Arthritides"[ti] OR "Degenerative Arthritis"[ti]
OR (oa[ti] AND knee) OR arthrosis[ti] OR "degenerative joint
disease"[ti] OR "degenerative joint diseases"[ti]) AND ("Synovial
Membrane"[Majr:noexp] OR synovium[ti] OR "Synovial
Membrane"[ti] OR "Synovial Membranes"[ti] OR "Synovial
tissue"[ti] OR "synovial tissues"[ti] OR Synovialis[ti])
2. ("osteoarthritis"[Majr] OR osteoarthritis[tiab] OR osteoarthritic[tiab]
OR Osteoarthritides[tiab] OR Osteoarthrosis[tiab] OR Osteoarthroses[tiab]
OR "Degenerative Arthritides"[tiab] OR "Degenerative Arthritis"[tiab]
OR (oa[tiab] AND knee) OR arthrosis[tiab]) AND ("Synovial
Membrane"[Majr:noexp] OR synovium[tiab] OR "Synovial
Membrane"[tiab] OR "Synovial Membranes"[tiab] OR "Synovial
tissue"[tiab] OR "synovial tissues"[tiab] OR Synovialis[tiab]) AND
(inﬂammatory[tw] OR "inﬂammation"[mesh] OR inﬂammation[tw]
OR "Synovitis"[mesh] OR synovitis[tw])
1460 1460
EMBASE (OVID-version 1. (exp *osteoarthritis/OR (osteoarthritis OR osteoarthritic OR
Osteoarthritides OR Osteoarthrosis OR Osteoarthroses OR "Degenerative
Arthritides" OR "Degenerative Arthritis" OR arthrosis OR "degenerative
joint disease" OR "degenerative joint diseases").ti OR (oa.ti AND knee.mp))
AND (*synovium/ OR ("Synovial Membrane" OR synovium OR "Synovial
Membrane" OR "Synovial Membranes" OR "Synovial tissue" OR
"synovial tissues" OR Synovialis).ti)
2. (exp *osteoarthritis/OR (osteoarthritis OR osteoarthritic OR Osteoarthritides
OR Osteoarthrosis OR Osteoarthroses OR "Degenerative Arthritides" OR
"Degenerative Arthritis" OR arthrosis OR "degenerative joint disease"
OR "degenerative joint diseases").ti,ab OR (oa.ti AND knee.ti,ab)) AND
(*synovium/ OR ("Synovial Membrane" OR synovium OR "Synovial
Membrane" OR "Synovial Membranes" OR "Synovial tissue" OR "synovial
tissues" OR Synovialis).ti,ab) AND (exp *inﬂammation/ OR inﬂammation.ti
OR inﬂammatory.ti OR exp *Synovitis/ OR synovitis.ti)
2.089 1018
Web of Science 1. TI¼((osteoarthriti* OR Osteoarthritides OR Osteoarthrosis OR
Osteoarthroses OR "Degenerative Arthritides" OR "Degenerative
Arthritis" OR arthrosis OR (oa AND knee)) AND (synovium OR "Synovial
Membrane" OR synovium OR "Synovial Membrane" OR "Synovial
Membranes" OR "Synovial tissue" OR "synovial tissues" OR Synovialis))
2. TS¼((osteoarthriti* OR Osteoarthritides OR Osteoarthrosis OR
Osteoarthroses OR "Degenerative Arthritides" OR "Degenerative
Arthritis" OR arthrosis OR (oa AND knee)) AND (synovium OR "Synovial
Membrane" OR synovium OR "Synovial Membrane" OR "Synovial
Membranes" OR "Synovial tissue" OR "synovial tissues" OR Synovialis)
AND (inﬂammat* OR synovitis))
1.271 382
Total 4820 2.860References
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